Estrogen Receptor alpha (ERα) and Insulin-like Growth Factor I Receptor (IGF-IR) cross-talk in the gonadotropic αT3-1 cell line

Journal of Cellular Physiology

Volumn 212, Issue 3, 2007, Pages 583-590

  Eertmans, Frank ^a   Dhooge, Willem ^a   De Wever, Olivier ^a   Bracke, Marc ^a   Comhaire, Frank ^a   Kaufman, Jean Marc ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

4 HYDROXYTAMOXIFEN; ANTIESTROGEN; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; FULVESTRANT; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SERINE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; GENETIC TRANSCRIPTION; GONADOTROPIN RELEASE; GONADOTROPIN SECRETING CELL; HORMONAL REGULATION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; MITOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; TRANSACTIVATION;

ANIMALS; BLOTTING, WESTERN; CELL PROLIFERATION; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR MODULATORS; FEMALE; GENES, REPORTER; GONADOTROPHS; HELA CELLS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LUCIFERASES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; PROMOTER REGIONS (GENETICS); RECEPTOR CROSS-TALK; RECEPTOR, IGF TYPE 1; RNA, MESSENGER; SELECTIVE ESTROGEN RECEPTOR MODULATORS; SIGNAL TRANSDUCTION; TAMOXIFEN; TRANSCRIPTION, GENETIC; TRANSFECTION;

MURINAE;

EID: 34547956513     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21053     Document Type: Article

References (50)

1. Alarid ET, Windle JJ, Whyte DB, Mellon PL. 1996. Immortalization of pituitary cells at discrete stages of development by directed oncogenesis in transgenic mice. Development 122:3319-3329.
2. Barletta F, Wong CW, McNally C, Komm BS, Katzenellenbogen B, Cheskis BJ. 2004. Characterization of the interactions of estrogen receptor and MNAR in the activation of cSrc. Mol Endocrinol 18:1096-1108.
3. Bunone G, Briand PA, Miksicek RJ, Picard D. 1996. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation. EMBO J 15:2174-2183.
4. Burger LL, Haisenleder DJ, Dalkin AC, Marshall JC. 2004. Regulation of gonadotropin subunit gene transcription. J Mol Endocrinol 33:559-584.
5. Cardona-Gomez GP, Mendez P, DonCarlos LL, Azcoitia I, Garcia-Segura LM. 2001. Interactions of estrogens and insulin-like growth factor-I in the brain: implications for neuroprotection. Brain Res Brain Res Rev 37:320-334.
6. Chen D, Washbrook E, Sarwar N, Bates GJ, Pace PE, Thirunuvakkarasu V, Taylor J, Epstein RJ, Fuller-Pace FV, Egly JM, Coombes RC, Ali S. 2002. Phosphorylation of human estrogen receptor alpha at serine 118 by two distinct signal transduction pathways revealed by phosphorylation-specific antisera. Oncogene 21:4921-4931.
7. Daftary SS, Gore AC. 2004. The hypothalamic insulin-like growth factor-1 receptor and its relationship to gonadotropin-releasing hormones neurones during postnatal development. J Neuroendocrinol 16:160-169.
8. Daftary SS, Gore AC. 2005. IGF-1 in the brain as a regulator of reproductive neuroendocrine function. Exp Biol Med 230:292-306.
9. Dluzen DE, McDermott JL. 2000. Neuroprotective role of estrogen upon methamphetamine and related neurotoxins within the nigrostriatal dopaminergic system. Ann N Y Acad Sci 914:112-126.
10. Goetz MP, Loprinzi CL. 2003. A hot flash on tamoxifen metabolism. J Natl Cancer Inst 95:1734-1735.
11. Harnish DC, Scicchitano MS, Adelman SJ, Lyttle CR, Karathanasis SK. 2000. The role of CBP in estrogen receptor cross-talk with nuclear factor-kappaB in HepG2 cells. Endocrinology 141:3403-3411.
12. Hiney JK, Srivastava V, Dearth RK, Dees WL. 2004. Influence of estradiol on insulin-like growth factor-1-induced luteinizing hormone secretion. Brain Res 1013:91-97.
13. Hubbard KB, Hepler JR. 2006. Cell signaling diversity of the Gqα family of heterotrimeric G proteins. Cell Signaling 18:135-150.
14. Kahlert S, Nuedling S, van Eickels M, Vetter H, Meyer R, Grohe C. 2000. Estrogen receptor alpha rapidly activates the IGF-1 receptor pathway. J Biol Chem 275:18447-18453.
15. Kato S, Endoh H, Masuhiro Y, Kitamoto T, Uchiyama S, Sasaki H, Masushige S, Gotoh Y, Nishida E, Kawashima H, Metzger D, Chambon P. 1995. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase. Science 270:1491-1494.
16. Klotz DM, Hewitt SC, Korach KS, DiAugustine RP. 2000. Activation of a uterine insulin-like growth factor I signaling pathway by clinical and environmental estrogens: requirement of estrogen receptor α. Endocrinology 141:3430-3439.
17. Knobil E. 1988. The neuroendocrine control of ovulation. Hum Reprod 3:469-472.
18. Lannigan DA. 2003. Estrogen receptor phosphorylation. Steroids 68:1-9.
19. Lee AV, Jackson JG, Gooch JL, Hilsenbeck SG, Coronado-Heinsohn E, Osborne CK, Yee D. 1999. Enhancement of insulin-like growth factor signaling in human breast cancer: estrogen regulation of insulin receptor substrate-1 expression in vitro and in vivo. Mol Endocrinol 13:787-796.
20. Levin ER. 2003. Bidirectional signaling between the estrogen receptor and the epidermal growth factor receptor. Mol Endocrinol 17:309-317.
21. Levin ER. 2005. Integration of the extranuclear and nuclear actions of estrogen. Mol Endocrinol 19:1951-1959.
22. Lipfert L, Fisher JE, Wei N, Scafonas A, Su Q, Yudkovitz J, Chen F, Warrier S, Birzin ET, Kim S, Chen HY, Tan Q, Schmidt A, Dininno F, Rohrer SP, Hammond ML, Rodan GA, Freedman LP, Reszka AA. 2006. Antagonist-induced, activation function-2-independent estrogen receptor α phosphorylation. Mol Endocrinol 20:516-533.
23. Malyala A, Kelly MJ, Ronnekleiv OK. 2005. Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes. Steroids 70: 397-406.
24. Manthey D, Behl C. 2006. From structural biochemistry to expression profiling: neuroprotective activities of estrogen. Neuroscience 138:845-850.
25. McDonnell DP, Clemm DL, Hermann T, Goldman ME, Pike JW. 1995. Analysis of estrogen receptor function in vitro reveals three distinct classes of antiestrogens. Mol Endocrinol 9:659-669.
26. Mellon PL, Windle JJ, Weiner RI. 1991. Immortalization of neuroendocrine cells by targeted oncogenesis. Recent Prog Horm Res 47:69-93.
27. Mendez P, Azcoitia I, Garcia-Segura LM. 2005. Interdependence of oestrogen and insulin-like growth factor-1 in the brain: potential for analysing neuroprotective mechanisms. J Endocrinol 185:11-17.
28. Metzger D, Berry M, Ali S, Chambon P. 1995. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol Endocrinol 9:579-591.
29. Moggs JG, Orphanides G. 2001. Orchestrators of pleiotropic cellular responses. EMBO J 2:775-781.
30. Nawaz Z, O'Malley BW. 2004. Urban renewal in the nucleus: is protein turnover by proteasomes absolutely required for nuclear receptor-regulated transcription? Mol Endocrinol 18:493-499.
31. Oesterreich S, Zhang P, Guler RL Sun X, Curran EM, Welshons WV, Osborne CK, Lee AV. 2001. Re-expression of estrogen receptor α in estrogen receptor α-negative MCF-7 cells restores both estrogen and insulin-like growth factor-mediated signaling and growth. Cancer Res 61:5771-5777.
32. Richards RG, DiAugustine RP, Petrusz P, Clark GC, Sebastian J. 1996. Estradiol stimulates tyrosine phosphorylation of the insulin-like growth factor-1 receptor and insulin receptor substrate-1 in the uterus. PNAS 93:12002-12007.
33. Rose A, Froment P, Perrot V, Quon MJ, LeRoith D, Dupont J. 2004. The luteinizing hormone-releasing hormone inhibits the anti-apoptotic activity of insulin-like growth factor-1 in pituitary αT3 cells by protein kinase Cα-mediated negative regulation of Akt. J Biol Chem 279:52500-52516.
34. Ruan W, Catanese V, Wieczorek R, Feldman M, Kleinberg DL. 1995. Estradiol enhances the stimulatory effect of insulin-like growth factor-1 (IGF-1) on mammary development and growth hormone-induced IGF-1 messenger ribonucleic acid. Endocrinology 136: 1296-1302.
35. Ruf F, Fink MY, Sealfon SC. 2003. Structure of the GnRH receptor-stimulated signaling network: insights from genomics. Front Neuroendocrinol 24:181-199.
36. Sato T, Wang G, Hardy MP, Kurita T, Cunha GR, Cooke PS. 2002. Role of systemic and local IGF-1 in the effects of estrogen on growth and epithelial proliferation of mouse uterus. Endocrinology 143:2673-2679.
37. Singer CA, Figueroa-Masot XA, Batchelor RH, Dorsa DM. 1999. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 19:2455-2463.
38. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR. 1990. New colorimetric cytotoxicity assay for anticancer - drug screening. J Natl Cancer Inst 82:1107-1112.
39. Soldani R, Cagnacci A, Paoletti AM, Yen SS, Melis GB. 1995. Modulation of anterior pituitary luteinizing hormone response to gonadotropin-releasing hormone by insulin-like growth factor I in vitro. Fertil Steril 64:634-637.
40. Song RXD, Santen RJ. 2006. Membrane initiated estrogen signaling in breast cancer. Biol Reprod 75:9-16.
41. Tilbrook AJ, Clarke IJ. 2001. Negative feedback regulation of the secretion and actions of gonadotropin-releasing hormone in males. Biol Reprod 64:735-742.
42. Topalli I, Etgen AM. 2004. Insulin-like growth factor-1 receptor and estrogen receptor crosstalk mediates hormone-induced neurite outgrowth in PC12 cells. Brain Res 1030:116-124.
43. Tzukerman MT, Esty A, Santiso-Mere D, Danielian P, Parker MG, Stein RB, Pike JW, McDonnell DP. 1994. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30.
44. Weiss JM, Chi M, Polack S, Diedrich K, Ortmann O. 2003. Interactions of insulin-like growth factors and estradiol in rat pituitary gonadotrophs. Growth Factors 21: 61-69.
45. Williams B, Brooks AN, Aldridge TC, Pennie WD, Stephenson R, McArdle CA. 2000. Oestradiol is a potent mitogen and modulator of GnRH signalling in alphaT 3-1 cells: are these effects causally related? J Endocrinol 164:31-43.
46. Wong CW, McNally C, Nickbarg E, Komm BS, Cheskis BJ. 2002. Estrogen receptor-interacting protein that modulates its non-genomic activity-crosstalk with Src/Erk phosphoryhtion cascade. PNAS 99:14783-14788.
47. Wyckoff MH, Chambliss KL, Mineo C, Yuhanna IS, Mendelsohn ME, Mumby SM, Shaul PW. 2001. Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Galpha(i). J Biol Chem 276:27071-27076.
48. Xia YX, Weiss JM, Polack S, Diedrich K, Ortmann O. 2001. Interactions of insulin-like growth factor-1, insulin and estradiol with GnRH-stimulated luteinizing hormone release from female rat gonadotrophs. Eur J Endocrinol 144:73-79.
49. Yuen T, Wurmbach E, Ebersole BJ, Ruf F, Pfeffer RL, Sealfon SC. 2002. Coupling of GnRH concentration and the GnRH receptor-activated gene program. Mol Endocrinol 16:1145-1153.
50. Zhang D, Trudeau VL. 2006. Integration of membrane and nuclear estrogen receptor signaling. Comp Biochem Physiol Mol Integr Physiol 144:306-315.